2020 Project: Emory University

Genomic, clinical, and phenotypic characterization of SARS-CoV-2 across a clinically and demographically diverse population in the southeastern United States

What to know

Emory University conducted a study to characterize the diversity and evolution of SARS-CoV-2 strains circulating in Georgia, to better understand population-level changes in the rates of viral spread, and to assess whether there were associations between viral genotype, the viral phenotype in vitro, and clinical phenotype/outcome.

Decorative image with words "2020" and "SARS-CoV-2"

Findings on SARS-CoV-2 surveillance and investigations

This project:

  • Developed a molecular assay to detect SARS-CoV-2 spike mutations associated with variants of concern.1
  • Determined SARS-CoV-2 had been circulating in the state of Georgia since mid-February 2020, three weeks prior to the state's first detected case. Together with studies from other geographic regions of the United States, the work underscored that there were multiple unidentified introductions of SARS-CoV-2 and that the virus was circulating more than was recognized by early diagnostic strategies which were trained on travelers returning to the US.2
  • Sequenced data contributed to an outbreak investigation among hemodialysis patients.3

Findings on SARS-CoV-2 Variant Characteristics

This project:

  • Isolated one of the earliest Omicron variant viruses in the U.S., which has now been used in multiple studies to assess neutralizing antibody responses and perform functional studies in vitro and in vivo.4
  • Described the emergence of immune escape mutations in immunocompromised patients treated with monoclonal antibodies.5